Takeshi Toyoda Selected Research

Takeshi Toyoda Research Topics

Disease

20	Carcinogenesis 01/2021 - 01/2007
17	Neoplasms (Cancer) 01/2021 - 11/2007
9	Body Weight (Weight, Body) 10/2021 - 07/2007
8	Infections 08/2017 - 01/2007
7	Inflammation (Inflammations) 01/2019 - 04/2008
7	Stomach Neoplasms (Stomach Cancer) 07/2013 - 01/2007
6	Hyperplasia 10/2022 - 04/2007
5	Gastritis 04/2016 - 04/2008
4	Hypertrophy 10/2022 - 05/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2020
2	Fibrosis (Cirrhosis) 01/2021 - 03/2012
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2020
2	Metaplasia 01/2019 - 04/2007
2	Hemorrhage 01/2019 - 10/2012
2	Adenocarcinoma 08/2017 - 08/2009
2	Necrosis 01/2017 - 04/2014
2	Papilloma (Papillomatosis) 10/2016 - 01/2011
2	Neurofibromatosis 2 (Neurofibromatosis Type II) 09/2012 - 03/2012
2	Malignant Mesothelioma 09/2012 - 03/2012
1	Virus Diseases (Viral Diseases) 02/2021
1	Asthma (Bronchial Asthma) 02/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Ganglion Cysts (Ganglion) 01/2021
1	Skin Neoplasms (Skin Cancer) 12/2018
1	Xeroderma Pigmentosum (Kaposi's Disease) 12/2018
1	Hypersensitivity (Allergy) 01/2018
1	Anemia 01/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2017
1	Obesity 01/2017
1	Cholangiocarcinoma 01/2017
1	Genomic Instability 12/2015

Drug/Important Bio-Agent (IBA)

14	CarcinogensIBA 01/2020 - 01/2007
6	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 04/2013 - 01/2007
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 04/2008
4	4-(methylthio)-3-butenyl isothiocyanateIBA 01/2019 - 10/2016
3	2-toluidine (o-toluidine)IBA 12/2020 - 01/2019
3	SaltsIBA 07/2013 - 01/2007
3	Transcription Factors (Transcription Factor)IBA 03/2012 - 03/2009
2	AminesIBA 01/2021 - 01/2020
2	2-anisidine (o-anisidine)IBA 01/2021 - 01/2019
2	AcetyltransferasesIBA 01/2021 - 01/2020
2	2-Acetylaminofluorene (2 Acetylaminofluorene)IBA 04/2019 - 07/2007
2	alpha-ChlorohydrinIBA 01/2017 - 07/2014
2	AsbestosIBA 09/2012 - 03/2012
2	Pharmaceutical PreparationsIBA 02/2010 - 10/2009
2	Methylnitronitrosoguanidine (MNNG)IBA 01/2009 - 01/2007
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2008 - 04/2008
2	Bromodeoxyuridine (BrdU)IBA 04/2008 - 04/2007
1	Hormones (Hormone)IBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Aldehyde DehydrogenaseIBA 01/2022
1	ButylhydroxybutylnitrosamineIBA 01/2022
1	Keratin-14 (Keratin 14)IBA 01/2022
1	Corn Oil (Oil, Corn)IBA 10/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021
1	desisobutyrylciclesonideIBA 02/2021
1	ciclesonide FDA Link 02/2021
1	von Willebrand FactorIBA 01/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2021
1	VimentinIBA 01/2021
1	SurvivinIBA 01/2021
1	guanylyl-(3'-5')-guanosineIBA 01/2021
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2021
1	1,3-dichloro-2-propanolIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 10/2020
1	Messenger RNA (mRNA)IBA 10/2020
1	DNA AdductsIBA 01/2020
1	ArsenicIBA 04/2019
1	Cacodylic Acid (Cacodylate)IBA 04/2019
1	HMGB2 ProteinIBA 04/2019
1	Arsenicals (Arsenic Compounds)IBA 04/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	ProlactinIBA 01/2019
1	Progesterone FDA LinkGeneric 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	5-hexenyl isothiocyanateIBA 12/2018
1	Rad30 proteinIBA 12/2018
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2018
1	MutagensIBA 01/2018
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2018
1	propylene dichlorideIBA 01/2017
1	Methylene Chloride (Dichloromethane)IBA 01/2017
1	nitrosobenzylmethylamineIBA 10/2016
1	Capsaicin (Zostrix)FDA Link 04/2016
1	piperineIBA 04/2016
1	melamineIBA 12/2015
1	phenethyl isothiocyanate (PEITC)IBA 12/2015
1	UracilIBA 12/2015
1	Diethylhexyl Phthalate (DEHP)IBA 05/2015
1	Serum AlbuminIBA 05/2015
1	GlobulinsIBA 05/2015
1	AlbuminsIBA 05/2015
1	Interleukin-6 (Interleukin 6)IBA 08/2014
1	EstersIBA 04/2014
1	DNA Repair EnzymesIBA 06/2013

Therapy/Procedure

2	Hepatectomy 01/2021 - 07/2007
2	Oral Administration 10/2019 - 01/2017
2	Chemoprevention 04/2016 - 08/2009
1	Nephrectomy 01/2021